Increased locomotor response to amphetamine induced by the repeated administration of the selective kappaâ•'opioid receptor
![Frontiers | Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson's Disease Frontiers | Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson's Disease](https://www.frontiersin.org/files/Articles/521268/fnagi-12-00068-HTML/image_m/fnagi-12-00068-g001.jpg)
Frontiers | Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson's Disease
![Pramipexole attenuates 6-OHDA-induced Parkinson's disease by mediating the Nurr1/NF-κB pathway | SpringerLink Pramipexole attenuates 6-OHDA-induced Parkinson's disease by mediating the Nurr1/NF-κB pathway | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs11033-021-06343-8/MediaObjects/11033_2021_6343_Fig4_HTML.png)
Pramipexole attenuates 6-OHDA-induced Parkinson's disease by mediating the Nurr1/NF-κB pathway | SpringerLink
![IgG1, Kappa from murine myeloma clone MOPC 21, purified immunoglobulin, buffered aqueous solution Mouse IgG1-kappa IgG1, Kappa from murine myeloma clone MOPC 21, purified immunoglobulin, buffered aqueous solution Mouse IgG1-kappa](https://www.sigmaaldrich.com/deepweb/content/dam/sigma-aldrich/product9/185/igg1_k-illustration.eps/_jcr_content/renditions/igg1_k-illustration-large.jpg)